# ABEMACICLIB
> **ANDA220238** · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARMACEUTICAL CO., LTD. · Approved 2025-11-06
## Drug
- **FDA Application Number:** ANDA220238
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABEMACICLIB
- **Generic name:** Abemaciclib
- **Active ingredients:** ABEMACICLIB
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** QILU PHARMACEUTICAL CO., LTD.
- **First approval:** 2025-11-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220238)
---
*AI Analytics · CC0 1.0*